Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 441 - 460 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 23  24  25 »
Reset 

National Patient Survey Highlights Healthcare Challenges for the 1 in 4 Americans Living with Rheumatic Disease

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019

Genmab Announces Positive Topline Results in Phase III Study of Daratumumab in Combination with Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019
Related companies:  Genmab A/S

The Eye Institute of Utah Among First in State to Offer PanOptix Trifocal IOL and the RxSight Light Adjustable Lens System

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019

Presentation och videointervju med Arcomas VD från Bolagsdagen den 12:e september.

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019
Related companies:  Arcoma AB

Sienna Announces September Dividend

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019

Change of Chairman at ALK

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019

Digirad Announces Listing and Trading of Preferred Stock on Nasdaq Global Market Under Symbol “DRADP”

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019
Related companies:  Digirad Corporation

Catalyst Pharmaceuticals, Inc. Determines Not to Proceed with Previously Announced Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019
Related companies:  Catalyst Pharmaceuticals, Inc.

Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin showed non-inferiority when compared to intravenous formulations for people with HER2-positive breast cancer

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Innate Pharma reports first half 2019 financial results and business update

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019
Related companies:  Innate Pharma S.A.

Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Heska Corporation Announces Pricing of $75.0 Million of 3.750% Convertible Senior Notes due 2026

LOVELAND, Colo., Sept. 12, 2019 /PRNewswire/ -- Heska Corporation (Nasdaq: HSKA; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty healthcare products, today announced the pricing of $75.0 million aggregate principal amount of convertible senior notes due 2026... Read more ››

By: PR Newswire Association LLC. - 13 Sep 2019
Related companies:  Heska Corporation

PDL BioPharma Announces Private Exchange of Approximately $86.1 Million of Convertible Notes Due 2024

INCLINE VILLAGE, Nev., Sept. 12, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that it has entered into separate privately negotiated transactions to exchange approximately $86.1 million in aggregate principal amount of its 2.75% Convertible... Read more ››

By: PR Newswire Association LLC. - 13 Sep 2019

Positive Results Announced From Phase 3 Trial Evaluating Fixed-Dose Subcutaneous Combination Of Perjeta® And Herceptin® Using Halozyme's Enhanze® Drug Delivery Technology

SAN DIEGO, Sept. 13, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced that the global phase III FeDeriCa study conducted by Genentech, a member of the Roche Group, met its primary endpoint.... Read more ››

By: PR Newswire Association LLC. - 13 Sep 2019
Related companies:  Halozyme Therapeutics, Inc.

Synergy Medical Ranks 382 on the 2019 Growth 500 List

LONGUEUIL, Quebec, Sept. 12, 2019 /PRNewswire/ -- Canadian Business and Maclean's today ranked Synergy Medical 382 on the annual Growth 500, the definitive ranking of Canada's Fastest-Growing Companies. Produced by Canada's premier business and current affairs media brands,... Read more ››

By: PR Newswire Association LLC. - 13 Sep 2019

SpringWorks Therapeutics Announces Pricing Of Initial Public Offering

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019
Related companies:  SpringWorks Therapeutics Inc.

UP International Grants Genomma Lab The Exclusive License For Novamil® / Novalac® Infant Nutrition Products In Mexico

MEXICO CITY, Sept. 12, 2019 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence is pleased to announce... Read more ››

By: PR Newswire Association LLC. - 13 Sep 2019

Turkey Medical Imaging Market 2019-2021: Four Manufacturers Control Approximately 80% of the Market

DUBLIN, Sept. 12, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 13 Sep 2019

Moretsky Cassidy Performs Successful PanOptix Trifocal Lens Implant

PHOENIX, Sept. 12, 2019 /PRNewswire/ -- We are proud to announce that Dr. Sanford Moretsky and Dr. Craig Cassidy, of Valley Eye Specialists, were amongst the first select group of eye surgeons nationally to implant the Alcon AcrySof(®) IQ PanOptix(® )Trifocal Intraocular Lens, after FDA approval.... Read more ››

By: PR Newswire Association LLC. - 13 Sep 2019

Fears Nachawati Opioid Litigation Trial Lawyers Encouraged by Purdue Pharma Settlement Talks

DALLAS, Sept. 12, 2019 /PRNewswire/ -- Trial lawyers for Dallas-based Fears Nachawati Law Firm are welcoming new developments in historic litigation against Big Pharma companies over damages caused by the reckless marketing and distribution of highly addictive opioid-based painkillers.

Read more ››
By: PR Newswire Association LLC. - 13 Sep 2019
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 23  24  25 »
to the top ↑